XenoPort Inc. (XNPT) was among the biggest gainers on the Russell 2000 for Friday February 19 as the stock popped 5.22% to $4.23, representing a gain of $0.21 per share. Some 588,276 shares traded hands on 2,831 trades, compared with an average daily volume of 1.31 million shares out of a total float of 63.21 million. The stock opened at $4.00 and traded with an intraday range of $4.31 to $3.91.
After today's gains, XenoPort Inc. reached a market cap of $267.37 million. XenoPort Inc. has had a trading range between $8.67 and $3.35 over the last year, and it had a 50-day SMA of $5.07 and a 200-day SMA of $5.81.
XenoPort Inc is a biopharmaceutical company. It is engaged in developing and commercializing a portfolio of internally discovered product candidates for the treatment of neurological and other disorders.
XenoPort Inc. is based out of Santa Clara, CA and has some 152 employees. Its CEO is Vincent J. Angotti.
For a complete fundamental analysis analysis of XenoPort Inc., check out Equities.com’s Stock Valuation Analysis report for XNPT. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.
The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.
Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.
For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.